372 related articles for article (PubMed ID: 18436554)
41. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH
BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018
[TBL] [Abstract][Full Text] [Related]
42. Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?
Grandesso S; Sapino B; Amici G; Mazzucato S; Solinas M; Gion M
New Microbiol; 2014 Oct; 37(4):503-8. PubMed ID: 25387287
[TBL] [Abstract][Full Text] [Related]
43. Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009).
Mendes RE; Farrell DJ; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):307-11. PubMed ID: 20955916
[TBL] [Abstract][Full Text] [Related]
44. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
[TBL] [Abstract][Full Text] [Related]
45. Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest.
Kulah C; Celebi G; Aktas E; Mengeloglu Z; Comert F; Ankarali H
J Chemother; 2009 Aug; 21(4):390-5. PubMed ID: 19622456
[TBL] [Abstract][Full Text] [Related]
46. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
47. Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.
Moon SY; Peck KR; Chang HH; Kim SW; Heo ST; Son JS; Ryu SY; Moon C; Jung SI; Shin SY; Lee JA; Joung MK; Chung DR; Kang CI; Song JH
Microb Drug Resist; 2012 Dec; 18(6):562-6. PubMed ID: 22775562
[TBL] [Abstract][Full Text] [Related]
48. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
Arroyo LA; Mateos I; González V; Aznar J
Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049
[No Abstract] [Full Text] [Related]
49. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
Casal M; Rodríguez F; Johnson B; Garduno E; Tubau F; de Lejarazu RO; Tenorio A; Giménez MJ; Bartolomé R; Garcia-Rey C; Aguilar L; García-Escribano N
J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133
[TBL] [Abstract][Full Text] [Related]
50. EVALUATION OF IN VITRO TIGECYCLINE ACTIVITY AGAINST MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII CLINICAL ISOLATES FROM POLAND.
Paluchowska P; Nowak P; Skalkowska M; Bjdak A
Acta Pol Pharm; 2017 May; 74(3):793-800. PubMed ID: 29513948
[TBL] [Abstract][Full Text] [Related]
51. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
[TBL] [Abstract][Full Text] [Related]
52. In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.
Park YK; Choi JY; Song JH; Ko KS
Int J Antimicrob Agents; 2009 Mar; 33(3):289-90. PubMed ID: 19091518
[No Abstract] [Full Text] [Related]
53. Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans.
Gajic I; Ranin L; Kekic D; Opavski N; Smitran A; Mijac V; Jovanovic S; Hadnadjev M; Travar M; Mijovic G
Acta Microbiol Immunol Hung; 2020 Mar; 67(3):176-181. PubMed ID: 32160781
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.
Cunha BA
J Clin Microbiol; 2009 May; 47(5):1613. PubMed ID: 19403778
[No Abstract] [Full Text] [Related]
55. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
[TBL] [Abstract][Full Text] [Related]
56. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
[TBL] [Abstract][Full Text] [Related]
57. Growing OXA-23 type strains among carbapenem-resistant
Altun Ş; Koçak Tufan Z; Altun B; Önde U; Kınıklı S; Demiröz AP
Turk J Med Sci; 2016 Dec; 46(6):1894-1899. PubMed ID: 28081345
[TBL] [Abstract][Full Text] [Related]
58. In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.
Ku NS; Lee SH; Lim YS; Choi H; Ahn JY; Jeong SJ; Shin SJ; Choi JY; Choi YH; Yeom JS; Yong D; Song YG; Kim JM
Sci Rep; 2019 Nov; 9(1):17127. PubMed ID: 31748527
[TBL] [Abstract][Full Text] [Related]
59. In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia.
Dhabaan GN; AbuBakar S; Shorman MA; Hassan H
J Chemother; 2012 Apr; 24(2):87-92. PubMed ID: 22546763
[TBL] [Abstract][Full Text] [Related]
60. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Housman ST; Hagihara M; Nicolau DP; Kuti JL
J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
